Also known as: Gerostateπ°
Developing novel therapeutics for aging and chronic disease
Company is closed
Event Year: 2018
Company is closed
Event Year: 2018
Gerostate Alpha was a venture focused on the development of innovative therapeutic interventions targeting the underlying mechanisms of aging and chronic diseases. The company aimed to address the growing need for effective treatments to improve healthspan and quality of life for an aging population. While the specific details of their approach remain undisclosed, the general direction involved pioneering research within the healthcare sector. Unfortunately, Gerostate Alpha is no longer active, suggesting challenges in their execution or market landscape.
Gerostate Alpha was a venture focused on the development of innovative therapeutic interventions targeting the underlying mechanisms of aging and chronic diseases. The company aimed to address the growing need for effective treatments to improve healthspan and quality of life for an aging population. While the specific details of their approach remain undisclosed, the general direction involved pioneering research within the healthcare sector. Unfortunately, Gerostate Alpha is no longer active, suggesting challenges in their execution or market landscape.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2018
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 6
Hiring: No
Team size: 6
Hiring: No